Comparative genomic hybridization identifies 17q11.2∼q12 duplication as an early event in cutaneous T-cell lymphomas

Cancer Genetics and Cytogenetics

Volumn 184, Issue 1, 2008, Pages 48-51

  Barba, Gianluca ^a   Matteucci, Caterina ^a   Girolomoni, Giampiero ^b   Brandimarte, Lucia ^a   Varasano, Emanuela ^a   Martelli, Massimo Fabrizio ^a   Mecucci, Cristina ^a  

^a IBiT Foundation   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; STAT PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 10; CHROMOSOME 10Q; CHROMOSOME 12P; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 2Q; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENE MAPPING; COMPARATIVE GENOMIC HYBRIDIZATION; CUTANEOUS T CELL LYMPHOMA; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIGENE FAMILY; MYCOSIS FUNGOIDES; ONCOGENE NEU; PRIORITY JOURNAL; SEZARY SYNDROME;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; KARYOTYPING; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; SKIN NEOPLASMS;

EID: 44949151159     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.03.007     Document Type: Article

References (27)

1. Siegel R.S., Pandolfino T., Guitart J., Rosen S., and Kuzel T.M. Primary cutaneous T-cell lymphomas: review and current concepts. [Erratum in: J Clin Oncol 2001;19:4185]. J Clin Oncol 18 (2000) 2908-2925
2. Kim E.J., Lin J., Junkins-Hopkins J.M., Vittorio C.C., and Rook A.H. Mycosis fungoides and Sezary syndrome: an update. Curr Oncol Rep 8 (2006) 376-386
3. Thangavelu M., Finn W.G., Yelavarthi K.K., Roenigk Jr. H.H., Samuelson E., Peterson L., Kuzel T.M., and Rosen S.T. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 89 (1997) 3371-3377
4. Whang-Peng J., Bunn Jr. P.A., Knutsen T., Matthews M.J., Schechter G., and Minna J.D. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 50 (1982) 1539-1553
5. Mao X., Lillington D., Scarisbrick J.J., Mitchell T., Czepulkowski B., Russell-Jones R., Young B., and Whittaker S.J. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides. Br J Dermatol 147 (2002) 464-475
6. Karenko L., Kähkönen M., Hyytinen E.-R., Lindlof M., and Ranki A. Notable losses at specific regions of chromosomes 10q and 13q in the Sézary Syndrome detected by comparative genomic hybridization. J Invest Dermatol 112 (1999) 392-395
7. Fischer T.C., Gellrich S., Muche J.M., Sherev T., Audring H., Neitzel H., Walden P., Sterry W., and Tonnies H. Genomic aberrations and survival in cutaneous T cell lymphomas. J Invest Dermatol 122 (2004) 579-586
8. Matteucci C., Galieni P., Leoncini L., Lazzi S., Lauria F., Polito E., Martelli M.F., and Mecucci C. Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol 200 (2003) 656-660
9. Kallioniemi O.-P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., and Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
10. El-Rifai W., Larramendy M.L., Björkqvist A.M., Hemmer S., and Knuutila S. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest 77 (1997) 699-700
11. Scarisbrick J.J., Woolford A.J., Russell-Jones R., and Whittaker S.J. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95 (2000) 2937-2942
12. Wain E.M., Mitchell T.J., Russell-Jones R., and Whittaker S.J. Fine mapping of chromosome 10q deletions in mycosis fungoides and Sezary syndrome: identification of two discrete regions of deletion at 10q23.33-24.1 and 10q24.33-25.1. Genes Chromosomes Cancer 42 (2005) 184-192
13. Katona T.M., O'Malley D.P., Cheng L., Hiatt K.M., Wang M., Anagnostou Jr. J.J., Billings S.D., and Smoller B.R. Loss of heterozygosity analysis identifies genetic abnormalities in mycosis fungoides and specific loci associated with disease progression. Am J Surg Pathol 31 (2007) 1552-1556
14. Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., and Parsons R. Germline mutation of PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16 (1997) 64-67
15. Palomero T., Sulis M.L., Cortina M., Real P.J., Barnes K., Ciofani M., Caparros E., Buteau J., Brown K., Perkins S.L., Bhagat G., Agarwal A.M., Basso G., Castillo M., Nagase S., Cordon-Cardo C., Parsons R., Zúñiga-Pflücker J.C., Dominguez M., and Ferrando A.A. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13 (2007) 1203-1210
16. Sakai A., Thieblemont C., Wellmann A., Jaffe E.S., and Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood 92 (1998) 3410-3415
17. Mao X., Lillington D.M., Czepulkovski B., Russell-Jones R., Young B.D., and Whittaker S. Molecular cytogenetic characterization of Sézary syndrome. Genes Chromosomes Cancer 36 (2003) 250-260
18. Espinet B., Salido M., Pujol R.M., Florensa L., Gallardo F., Domingo A., Servitje O., Estrach T., García-Muret P., Woessner S., Serrano S., and Solé F. Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situ hybridization. Haematologica 89 (2004) 165-173
19. Eriksen K.W., Kaltoft K., Mikkelsen G., Nielsen M., Zhang Q., Geisler C., Nissen M.H., Röpke C., Wasik M.A., and Odum N. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia 15 (2001) 787-793
20. Zhang Q., Nowak I., Vonderheid E.C., Rook A.H., Kadin M.E., Nowell P.C., Shaw L.M., and Wasik M.A. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A 93 (1996) 9148-9153
21. Qin J.Z., Kamarashev J., Zhang C.L., Dummer R., Burg G., and Dobbeling U. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 98 (2001) 2778-2783
22. Mitchell T.J., Whittaker S.J., and John S. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary syndrome. Cancer Res 63 (2003) 9048-9054
23. Baśkiewicz-Masiuk M., Masiuk M., and Machaliński B. The influence of STAT5 antisense oligonucleotides on the proliferation and apoptosis of selected human leukaemic cell lines. Cell Prolif 36 (2003) 265-278
24. van Kester M.S., Out-Luiting J.J., von dem Borne P.A., Willemze R., Tensen C.P., and Vermeer M.H. Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells. J Invest Dermatol (2008 Jan 17) [Epub ahead of print]
25. Ferretti G., Felici A., Papaldo P., Fabi A., and Cognetti F. HER2/neu role in breast cancer: from a prognostic foe to a predictive friend. Curr Opin in Obstet Gynecol 19 (2007) 56-62
26. Utikal J., Poenitz N., Gratchev A., Klemke C.D., Nashan D., Tuting T., and Goerdt S. Additional Her2/neu gene copies in patients with Sézary syndrome. Leuk Res 30 (2006) 755-760
27. Girardi M., Heald P.W., and Wilson L.D. The pathogenesis of mycosis fungoides. N Engl J Med 350 (2004) 1978-1988